Leap Therapeutics, Inc. Gains 34.58%

Fri, May 13, 2022 at 05:30 PM

Leap Therapeutics, Inc. (LPTX:NASDAQ) shot up at $1.31, representing a gain of 34.6%. On Thu, May 12, 2022, LPTX:NASDAQ touched a New 2-Week Low of $0.97. The stock got featured on our News Catalysts scanner on Fri, May 13, 2022 at 09:51 AM in the 'EARNINGS' category. From Thu, Apr 28, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days

The stock spiked on Mon, Jan 03, 2022 at $3.45 with a volume of 2M+.

About Leap Therapeutics, Inc. (LPTX:NASDAQ)

Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

Top 10 Gainers:

ShiftPixy, Inc. (PIXY:NASDAQ), 154.87%
PolarityTE, Inc. (PTE:NASDAQ), 44.51%
Veru Inc. (VERU:NASDAQ), 43.96%
Calithera Biosciences, Inc. (CALA:NASDAQ), 42.77%
View Inc. (VIEW:NASDAQ), 38.7%
Inotiv Inc. (NOTV:NASDAQ), 38.38%
Amyris, Inc. (AMRS:NASDAQ), 37.21%
Leap Therapeutics, Inc. (LPTX:NASDAQ), 34.58%
Molecular Data Inc. (MKD:NASDAQ), 34.51%
Expensify Inc. (EXFY:NASDAQ), 34.45%